The combined use of tigecycline with high-dose colistin might not be associated with higher survival in critically ill patients with bacteraemia due to carbapenem-resistant Acinetobacter baumannii

IRENE GRACIA AHUFINGERJULIAN CARLOS DE LA TORRE CISNEROSELENA PÉREZ NADALES2026-01-292026-01-29201810.1016/j.cmi.2017.09.0162-s2.0-85034959520https://www.scopus.com/inward/record.uri?eid=2-s2.https://ucocris.uco.es/handle/123456789/28660Infectious DiseasesMicrobiology (medical)The combined use of tigecycline with high-dose colistin might not be associated with higher survival in critically ill patients with bacteraemia due to carbapenem-resistant Acinetobacter baumanniiresearch article